![Sergey Yurasov](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sergey Yurasov
Chief Tech/Sci/R&D Officer at
BLACK DIAMOND THERAPEUTICS, INC.
Net worth: 40 699 $ as of 2026-07-30
Profile
Sergey Yurasov currently works at Black Diamond Therapeutics, Inc., as Chief Medical Officer from 2022.
Dr. Yurasov also formerly worked at Hoffman-La Roche, Inc., as Clinical Director-Oncology & Pharma Research, ImClone LLC, as Associate Vice President-Global Medicine Science, The Rockefeller University, as Assistant Professor-Clinical Investigation, Immune Design Corp., as Chief Medical Officer & SVP-Clinical Development from 2016 to 2019, Clovis Oncology, Inc., as Senior Vice President-Clinical Development in 2016, and Nuvation Bio, Inc., as Chief Medical Officer from 2019 to 2022.
Dr. Yurasov received his doctorate degree from Russian State Medical University and doctorate degree from Research Institute for Pediatric Oncology.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-04-26 | 24,082 ( 0.04% ) | 40 699 $ | 2026-07-30 |
Sergey Yurasov active positions
| Companies | Position | Start |
|---|---|---|
| BLACK DIAMOND THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2022-05-31 |
Former positions of Sergey Yurasov
| Companies | Position | End |
|---|---|---|
| NUVATION BIO INC. | Chief Tech/Sci/R&D Officer | 2022-01-31 |
| IMMUNE DESIGN CORP | Chief Tech/Sci/R&D Officer | 2019-04-01 |
| CLOVIS ONCOLOGY, INC. | Corporate Officer/Principal | 2016-08-31 |
The Rockefeller University
 The Rockefeller University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Hoffman-La Roche, Inc.
 Hoffman-La Roche, Inc. Pharmaceuticals: MajorHealth Technology Researches, develops and manufactures medicines, diagnostics and vitamins | Corporate Officer/Principal | - |
Training of Sergey Yurasov
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
53
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology Develops novel therapeutic products and blood cell growth factors for the treatment of cancer | Health Technology |
The Rockefeller University
The Rockefeller University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immune Design Corp.
 Immune Design Corp. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical and clinical-stage immunotherapy company | Health Technology |
Russian State Medical University
 Russian State Medical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Clovis Oncology, Inc.
 Clovis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as an biopharmaceutical company that acquires, develops and commercializes innovative anti cancer agents | Health Technology |
Hoffman-La Roche, Inc.
Hoffman-La Roche, Inc. Pharmaceuticals: MajorHealth Technology Researches, develops and manufactures medicines, diagnostics and vitamins | Health Technology |
Research Institute for Pediatric Oncology
 Research Institute for Pediatric Oncology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Black Diamond Therapeutics, Inc.
 Black Diamond Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops precision medicines for cancer | Health Technology |
Nuvation Bio, Inc.
 Nuvation Bio, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops oncology related novel therapeutic candidates | Health Technology |
- Stock Market
- Insiders
- Sergey Yurasov
